PS this bit was mouthwatering in the article... "Publication of the full article, including supporting analysis, will be a game changing near term catalyst for NTI which will be immediately followed by a US FDA submission."
It's all about the supporting analysis to prove it's statistical significance to justify lodging to the FDA now. IF it is good this will re-rate hard IMO...
Cheers
Red bar
